A phase lb dose escalation trial of isatuximab (SAR650984, anti-CD38 mAb) plus lenalidomide and dexamethasone (Len/Dex) in relapsed/refractory multiple myeloma (RRMM): Interim results from two new dose cohorts Meeting Abstract
| Authors: | Vij, R.; Lendvai, N.; Martin, T. G.; Baz, R. C.; Campana, F.; Mazuir, F.; Charpentier, E.; Benson, D. M. |
| Abstract Title: | A phase lb dose escalation trial of isatuximab (SAR650984, anti-CD38 mAb) plus lenalidomide and dexamethasone (Len/Dex) in relapsed/refractory multiple myeloma (RRMM): Interim results from two new dose cohorts |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 418s |
| Language: | English |
| ACCESSION: | WOS:000404711505165 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.8009 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8009 -- Source: Wos |
